Two-dimension Tailor-made Therapy: A New Salvage Therapy After Multiple Eradication Failures for Helicobacter pylori Infection

Two-dimension Tailor-made Therapy: A New Salvage Therapy After Multiple Eradication Failures for Helicobacter pylori Infection

Background and Aims: Vonoprazan-based eradication therapies have a higher eradication rate than usual proton pump inhibitor (PPI)–based therapies in treating Helicobacter pylori infection. Should we use vonoprazan to treat patients who failed multiple eradication therapies? Because the drug is not a...

Full description

Bibliographic Details
Main Authors: Shigemi Nakajima, Hisayuki Inoue, Hiroshi Satake, Rena Chatani, Mariko Ohara, Yuki Tsubakimoto, Makoto Fujii, Hiroshi Hasegawa, Keiko Takahashi, Kiyoyuki Hayafuji, Yoshihide Fujiyama
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Gastro Hep Advances
Subjects:
Vonoprazan
Proton Pump Inhibitor
CYP2C19 Genotype
Antibiotics Susceptibility Test
Third-line Therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2772572321000327

Internet

http://www.sciencedirect.com/science/article/pii/S2772572321000327

Similar Items